OpenURL Connection Search

Select item for more details and to access through your institution.

Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia.
Published in:
American Journal of Hematology, 2023, v. 98, n. 12, p. E360, doi. 10.1002/ajh.27092
By:
- Patel, Parth C.;
- Ball, Somedeb;
- Jain, Akriti G.;
- Wang, Chen;
- Hussaini, Mohammad O.;
- Aguirre, Luis E.;
- Chan, Onyee;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
Published in:
American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
By:
- Fleti, Farah;
- Chan, Onyee;
- Singh, Amritpal;
- Abdelmagid, Maymona G.;
- Al‐Kali, Aref;
- Elliott, Michelle A.;
- Begna, Kebede H.;
- Foran, James M.;
- Badar, Talha;
- Khera, Nandita;
- Al Ali, Najla H.;
- Padron, Eric;
- Sallman, David A.;
- Shah, Mithun;
- Hiwase, Devendra;
- Pardanani, Animesh;
- Arber, Daniel A.;
- Orazi, Attilio;
- Reichard, Kaaren K.;
- He, Rong
Publication type:
Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Published in:
American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Aguirre, Luis E.;
- Al Ali, Najla;
- Zhang, Yumeng;
- Chan, Onyee;
- Kuykendall, Andrew T.;
- Sweet, Kendra L.;
- Lancet, Jeffrey E.;
- Swoboda, David M.;
- Padron, Eric;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic.
Published in:
American Journal of Hematology, 2020, v. 95, n. 8, p. E203, doi. 10.1002/ajh.25853
By:
- Patnaik, Mrinal M.;
- Lasho, Terra;
- Padron, Eric;
- McCullough, Kristen;
- Al‐kali, Aref;
- Tefferi, Ayalew;
- Zeidan, Amer M.;
- Gangat, Naseema;
- Savona, Michael;
- Steensma, David P.;
- Solary, Eric
Publication type:
Article
Driver mutation‐specific clinical and genomic correlates differ between primary and secondary myelofibrosis.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. E314, doi. 10.1002/ajh.25625
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Sallman, David;
- Komrokji, Rami S.
Publication type:
Article
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients.
Published in:
American Journal of Hematology, 2019, v. 94, n. 1, p. 87, doi. 10.1002/ajh.25335
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Published in:
American Journal of Hematology, 2017, v. 92, n. 3, p. 232, doi. 10.1002/ajh.24627
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- Sweet, Kendra;
- Al Ali, Najla H.;
- Padron, Eric;
- Kubal, Timothy E.;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Autoimmune diseases and myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2016, v. 91, n. 5, p. E280, doi. 10.1002/ajh.24333
By:
- Komrokji, Rami S.;
- Kulasekararaj, Austin;
- Al Ali, Najla H.;
- Kordasti, Shahram;
- Bart-Smith, Emily;
- Craig, Benjamin M.;
- Padron, Eric;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Pinilla-Ibarz, Javier;
- List, Alan F.;
- Mufti, Ghulam J.;
- Epling-Burnette, Pearlie K.
Publication type:
Article
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?
Published in:
American Journal of Hematology, 2015, v. 90, n. 11, p. 1036, doi. 10.1002/ajh.24173
By:
- Zeidan, Amer M.;
- Sekeres, Mikkael A.;
- Wang, Xiao-Feng;
- Al Ali, Najla;
- Garcia-Manero, Guillermo;
- Steensma, David P.;
- Roboz, Gail;
- Barnard, John;
- Padron, Eric;
- DeZern, Amy;
- Maciejewski, Jaroslaw P.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
Article
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2014, v. 89, n. 8, p. 809, doi. 10.1002/ajh.23749
By:
- Komrokji, Rami S.;
- Padron, Eric;
- Yu, Daohai;
- Fulp, William J.;
- Rodriguez, Yuraima;
- Tinsley, Sara;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2013, v. 88, n. 7, p. 566, doi. 10.1002/ajh.23454
By:
- Mishra, Asmita;
- Corrales-Yepez, Maria;
- Ali, Najla Al;
- Kharfan-Dabaja, Mohamed;
- Padron, Eric;
- Zhang, Ling;
- Epling-Burnette, Pearlie K.;
- Pinilla-Ibarz, Javier;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
Article
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2012, v. 87, n. 11, p. 1006, doi. 10.1002/ajh.23303
By:
- Komrokji, Rami S.;
- Corrales-Yepez, Maria;
- Kharfan-Dabaja, Mohamed A.;
- Al Ali, Najla H.;
- Padron, Eric;
- Rollison, Dana E.;
- Pinilla-Ibarz, Javier;
- Zhang, Ling;
- Epling-Burnette, Pearlie K.;
- Lancet, Jeffrey E.;
- List, Alan F.
Publication type:
Article
Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia.
Published in:
Current Hematologic Malignancy Reports, 2021, v. 16, n. 3, p. 247, doi. 10.1007/s11899-021-00613-9
By:
- Hunter, Anthony;
- Padron, Eric
Publication type:
Article
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.
Published in:
Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 543, doi. 10.1007/s11899-019-00553-5
By:
- Kuykendall, Andrew T.;
- Padron, Eric
Publication type:
Article
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Published in:
Current Hematologic Malignancy Reports, 2016, v. 11, n. 6, p. 425, doi. 10.1007/s11899-016-0350-1
By:
- Talati, Chetasi;
- Padron, Eric
Publication type:
Article
Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Published in:
Oncologist, 2017, v. 22, n. 2, p. 144, doi. 10.1634/theoncologist.2016-0195
By:
- Knepper, Todd C.;
- Bell, Gillian C.;
- Hicks, J. Kevin;
- Padron, Eric;
- Teer, Jamie K.;
- Vo, Teresa T.;
- Gillis, Nancy K.;
- Mason, Neil T.;
- McLeod, Howard L.;
- Walko, Christine M.
Publication type:
Article
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 459, doi. 10.1016/j.clml.2024.03.001
By:
- Aguirre, Luis E.;
- Jain, Akriti;
- Ball, Somedeb;
- Ali, Najla Al;
- Volpe, Virginia O.;
- Tinsley-Vance, Sara;
- Sallman, David;
- Sweet, Kendra;
- Lancet, Jeffrey;
- Padron, Eric;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Komrokji, Rami
Publication type:
Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
By:
- Ionescu, Filip;
- David, Jerel C.;
- Ravichandran, Apoorva;
- Sallman, David A.;
- Sweet, Kendra;
- Komrokji, Rami S.;
- Chan, Onyee;
- Kuykendall, Andrew;
- Padron, Eric;
- Faramand, Rawan;
- Bejanyan, Nelli;
- Khimani, Farhad;
- Elmariah, Hany;
- Pidala, Joseph;
- Mishra, Asmita;
- Perez, Lia;
- Nishihori, Taiga;
- Lancet, Jeffrey E.
Publication type:
Article
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
By:
- Jain, Akriti G.;
- Ball, Somedeb;
- Aguirre, Luis E.;
- Tobon, Katherine A.;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David;
- Lancet, Jeffrey E.;
- Sweet, Kendra
Publication type:
Article
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 355, doi. 10.1016/j.clml.2023.01.007
By:
- Tinsley-Vance, Sara M;
- Ali, Najla Al;
- Ball, Somedeb;
- Aguirre, Luis E;
- Jain, Akriti G;
- Hussaini, Mohammad Omar;
- Chan, Onyee;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Lancet, Jeffrey;
- Padron, Eric;
- Sallman, David A;
- Komrokji, Rami S
Publication type:
Article
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e150, doi. 10.1016/j.clml.2022.12.008
By:
- Zhang, Yumeng;
- Nguyen, Lynn;
- Lu, Chuanyi M.;
- Wang, Endi;
- Lauw, Marietya I.S.;
- Ball, Somedeb;
- Dong, Ning;
- Moscinski, Lynn;
- Chan, Onyee;
- Yun, Seongseok;
- Sallman, David;
- Sokol, Lubomir;
- Shah, Bijal;
- Knepper, Todd;
- Lancet, Jeffery;
- Komrokji, Rami;
- Padron, Eric;
- Kuykendall, Andrew;
- Zhang, Ling
Publication type:
Article
CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 774, doi. 10.1016/j.clml.2022.06.001
By:
- Lee, Dasom;
- Jain, Akriti G;
- Deutsch, Yehuda;
- Eatrides, Jennifer;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Lancet, Jeffrey;
- Sallman, David;
- Talati, Chetasi;
- Sweet, Kendra
Publication type:
Article
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e521, doi. 10.1016/j.clml.2022.01.015
By:
- Tokumori, Franco Castillo;
- Ali, Najla Al;
- Chan, Onyee;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew T.
Publication type:
Article
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e467, doi. 10.1016/j.clml.2022.01.002
By:
- Chan, Onyee;
- Ali, Najla Al;
- Sallman, David;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01826-7
By:
- Horvat, Nathan P.;
- Komrokji, Rami;
- Ali, Najla Al;
- Talati, Chetasi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Chan, Onyee;
- Lancet, Jeffrey;
- Kuykendall, Andrew T.
Publication type:
Article
MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S358, doi. 10.1016/S2152-2650(21)01825-5
By:
- Tokumori, Franco Castillo;
- Talati, Chetasi;
- Ali, Najla Al;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew
Publication type:
Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S341, doi. 10.1016/S2152-2650(21)01794-8
By:
- Ali, Najla Al;
- Sallman, David;
- Onyee Chan;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S309, doi. 10.1016/S2152-2650(21)01733-X
By:
- Chan, Onyee;
- Ali, Najla Al;
- Yun, Seongseok;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Komrokji, Rami;
- Lancet, Jeffrey
Publication type:
Article
AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S293, doi. 10.1016/S2152-2650(21)01700-6
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Al Ali, Najla;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S286, doi. 10.1016/S2152-2650(21)01686-4
By:
- Volpe, Virginia;
- Vincelette, Nicole;
- Logothetis, Constantine;
- Onyee Chan;
- Talati, Chetasi;
- Sweet, Kendra;
- Calon, Gregoire;
- Horvat, Nathan;
- Kuykendall, Andrew;
- Sallman, David;
- Padron, Eric;
- Komrokji, Rami;
- Ling Zhang;
- Lancet, Jeffrey;
- Seongseok Yun
Publication type:
Article
Poster: MPN-244: Comorbid Conditions Occur Frequently and Correlate with Early Disease Progression and Poor Outcomes in Young Patients with Myelofibrosis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01460-9
By:
- Horvat, Nathan P.;
- Komrokji, Rami;
- Ali, Najla Al;
- Talati, Chetasi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Onyee Chan;
- Lancet, Jeffrey;
- Kuykendall, Andrew T.
Publication type:
Article
Poster: MPN-236: Different Treatment Approaches to Blast-Phase Myeloproliferative Neoplasms.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S232, doi. 10.1016/S2152-2650(21)01459-2
By:
- Tokumori, Franco Castillo;
- Talati, Chetasi;
- Ali, Najla Al;
- Sallman, David;
- Seongseok Yun;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew
Publication type:
Article
Poster: MDS-128: Azacitidine and Venetoclax Combination for Upfront Treatment of Higher-Risk Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01428-2
By:
- Al Ali, Najla;
- Sallman, David;
- Onyee Chan;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Al Ali, Najla;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S214, doi. 10.1016/S2152-2650(21)01345-8
By:
- Chan, Onyee;
- Ali, Najla Al;
- Yun, Seongseok;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Komrokji, Rami;
- Lancet, Jeffrey
Publication type:
Article
Poster: AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01340-9
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Ali, Najla Al;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E.;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Poster: AML-170: High MYC Expression Predicts Poor Survival Outcomes in IDH1/2 Mutant AML Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01331-8
By:
- Volpe, Virginia;
- Vincelette, Nicole;
- Logothetis, Constantine;
- Chan, Onyee;
- Talati, Chetasi;
- Sweet, Kendra;
- Calon, Gregoire;
- Horvat, Nathan;
- Kuykendall, Andrew;
- Sallman, David;
- Padron, Eric;
- Komrokji, Rami;
- Zhang, Ling;
- Lancet, Jeffrey;
- Yun, Seongseok
Publication type:
Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Published in:
2021
By:
- Gesiotto, Quinto J.;
- Swoboda, David M.;
- Shallis, Rory M.;
- Al Ali, Najla;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Song, Jinming;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Zeidan, Amer M.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Published in:
2021
By:
- Schwabkey, Zaker I.;
- Al Ali, Najla;
- Chan, Onyee;
- Sallman, David A.;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
journal article
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
Published in:
2020
By:
- Castillo-Tokumori, Franco;
- Talati, Chetasi;
- Al Ali, Najla;
- Sallman, David;
- Yun, Seongseok;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- Komrokji, Rami;
- Kuykendall, Andrew T.
Publication type:
journal article
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.
Published in:
2020
By:
- Sallman, David A.;
- Barnard, John;
- Al Ali, Najla H.;
- Garcia-Manero, Guillermo;
- Sekeres, Mikkael A.;
- DeZern, Amy;
- Steensma, David P.;
- Roboz, Gail;
- Jabbour, Elias;
- Maciejewski, Jaroslaw P.;
- Pierce, Sherry;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Kantarjian, Hagop;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.
Published in:
2020
By:
- Zhang, Qing;
- Haider, Mintallah;
- Al Ali, Najla H.;
- Lancet, Jeffrey E.;
- Epling-Burnette, Pearlie K.;
- List, Alan F.;
- Padron, Eric;
- Komrokji, Rami S.
Publication type:
journal article
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes.
Published in:
2020
By:
- Melody, Megan;
- Al Ali, Najla;
- Zhang, Ling;
- Ramadan, Hanadi;
- Padron, Eric;
- Sallman, David;
- Sweet, Kendra;
- Lancet, Jeffrey;
- List, Alan;
- Bennett, John M.;
- Komrokji, Rami
Publication type:
journal article
Defining Acute Myeloid Leukemia Ontogeny in Older Patients.
Published in:
2020
By:
- Melody, Megan;
- Kuykendall, Andrew;
- Sallman, David;
- Al Ali, Najla;
- Zhang, Ling;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Extermann, Martine;
- List, Alan;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
journal article
Lenalidomide and Thalidomide are Active in MF-Related Anemia, but Differ in Duration of Response and Association of Benefit with Outcome.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S350, doi. 10.1016/j.clml.2019.07.363
By:
- Kuykendall, Andrew;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan;
- Lancet, Jeffrey;
- Komrokji, Rami
Publication type:
Article
Ring Sideroblast Quantification is Highly Predictive of TP53 Mutation in MDS with Excessive Blasts with Prognostic Implications.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S344, doi. 10.1016/j.clml.2019.07.350
By:
- Swoboda, David;
- Lee, Jung-Hoon;
- Chan, Onyee;
- Komrokji, Rami;
- Al Ali, Najla;
- Padron, Eric;
- List, Alan;
- Hussaini, Mohammad;
- Song, Jinming;
- Sallman, David
Publication type:
Article
Hypoplastic MDS in the Elderly: A Single Institutional Experience.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.344
By:
- Wang, Emilie;
- Al Ali, Najla;
- Sallman, David;
- Padron, Eric;
- Kuykendall, Andrew;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey;
- List, Alan;
- Komrokji, Rami
Publication type:
Article
Venetoclax Combination with Hypomethylating Agents for Treatment of Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S339, doi. 10.1016/j.clml.2019.07.340
By:
- Al Ali, Najla;
- Sallman, David;
- Nelson, Rebecca;
- Talati, Chetasi;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Padron, Eric;
- Lancet, Jeffrey;
- List, Alan;
- Komrokji, Rami
Publication type:
Article

Found: 113